Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-19-000004

Chief Science/Medical Officer acquired 85,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
STRAYER DAVID R Chief Science/Medical Officer 2019-03-25 Conversion +50,000 94,304 D: show line 1 in the form
STRAYER DAVID R Chief Science/Medical Officer 2019-05-08 Conversion +35,000 129,304 D: show line 2 in the form
Loading xslF345X03/primary_doc.xml…